At a glance
- Originator Eli Lilly and Company
- Class Antifungals; Antiprotozoals
- Mechanism of Action Glucan synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 01 May 1997 New profile
- 01 May 1997 Discontinued-Preclinical for Mycoses in USA (IV)